About drug profile configurations

A drug profile configuration is the specification of which data mining runs and which report outputs are the source of charts that users can add to a drug profile layout (on the Drug Profile page). To access the Drug Profile page, a user must set a drug profile configuration as a user preference.

For example, a drug profile configuration specifies that for generic drugs, the MGPS 2D run is 2019Q4: Generic (S + C). In a drug profile, users who have that configuration set as a user preference can add charts for a generic drug based on the results of the 2019Q4: Generic (S + C) run.

Note:

Drug profile configurations are separate from drug profile layouts. Drug profile layouts, which are saved collections of charts as well as their placement and display options, can be used with various drug profile configurations. For example, if you are using the layout, Generic + trade comparators, and you change your user preference to a different drug profile configuration, the Generic + trade comparators layout is still available.

Only report outputs from an all cases summary report can be used in a drug profile configuration. This is a special type of interactive report that must meet certain criteria.

In the drug profile configuration, you can specify data mining runs and report outputs for generic names, trade names, and ingredients. To specify a run or report output, you can select either the run name or an alias that has been set up for the run or report output.

You might want to create multiple drug profile configurations for different purposes. For example, you can set up one drug profile configuration for AERS data and another drug profile configuration for proprietary data. For information on setting up the drug profiles feature, see Set up a drug profile.